Comparison

LY-195448 (hydrochloride) European Partner

Item no. HY-119200
Manufacturer MedChem Express
CASRN 111112-18-6
Amount 1 ea
Category
Type Standard
Specific against other
Citations [1]Phase I clinical and pharmacokinetic study of LY 195448
Smiles NC(C(C=C1)=CC=C1CCC(C)(C)NC[C@@H](C2=CC=CC=C2)O)=O.Cl
ECLASS 10.1 42021590
ECLASS 11.0 42021590
UNSPSC 12352202
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
Endogenous Metabolite
Shipping Temperature
Room temperature
Molecular Weight
362.89
Product Description
LY-195448 hydrochloride is a phenethanolamine that exhibits anti-tumour activity across various murine tumour models. LY-195448 hydrochloride acts by blocking cells at metaphase. LY-195448 hydrochloride has demonstrated a lack of "standard" side effects commonly associated with cancer treatments, such as myelosuppression and gastrointestinal toxicity. LY-195448 hydrochloride was evaluated in a phase I trial, where it showed only mild and reversible side effects like hypotension, tachycardia, and tremor.
Manufacturer - Research Area
Cancer
Manufacturer - Pathway
Metabolic Enzyme/Protease
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close